L. Frantzen

ORCID: 0000-0003-3884-6020
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Healthcare Systems and Practices
  • Oral and gingival health research
  • Dialysis and Renal Disease Management
  • HIV/AIDS oral health manifestations
  • Oral microbiology and periodontitis research
  • Central Venous Catheters and Hemodialysis
  • Muscle and Compartmental Disorders
  • Oral Health Pathology and Treatment
  • COVID-19 Clinical Research Studies
  • Blood Pressure and Hypertension Studies
  • SARS-CoV-2 and COVID-19 Research
  • Health, Medicine and Society
  • Dental Health and Care Utilization
  • Vaccine Coverage and Hesitancy
  • Renal Diseases and Glomerulopathies
  • Neurological Complications and Syndromes
  • Potassium and Related Disorders
  • Iron Metabolism and Disorders
  • Cystic Fibrosis Research Advances
  • Health Systems, Economic Evaluations, Quality of Life
  • Sympathectomy and Hyperhidrosis Treatments
  • CNS Lymphoma Diagnosis and Treatment
  • Uterine Myomas and Treatments
  • Sexual function and dysfunction studies
  • Ferroelectric and Negative Capacitance Devices

Hôpital Saint Joseph
2021-2023

Diversité, adaptation et développement des plantes
2012-2015

Hôpital Civil, Strasbourg
2005

Nephrologists call for priority access to coronavirus disease 2019 vaccination in patients receiving in-centre haemodialysis [1] two main reasons: a very high risk of severe acute respiratory syndrome 2 (SARS-CoV-2) infection compared with the general population (5-16 times more likely [2] because they travel their dialysis centre three week and are surrounded by other caregivers) also particular mortality rate (close 20%) when infected SARS-CoV-2 [3].Our team is taking care 470 Marseille...

10.1093/ndt/gfab165 article EN other-oa Nephrology Dialysis Transplantation 2021-04-23
Suetonia C. Palmer Marinella Ruospo Germaine Wong Jonathan C. Craig Massimo Petruzzi and 95 more Michele De Benedittis Pauline Ford David W. Johnson Marcello Tonelli Patrizia Natale Valeria Saglimbene Fabio Pellegrini Eduardo Celia Rubén Gelfman Miguel Leal Mariëtta Török Paul Stroumza Anna Bednarek-Skublewska Jan Duława L. Frantzen Juan Nin Ferrari Domingo del Castillo Amparo Bernat Jörgen Hegbrant Charlotta Wollheim Letizia Gargano Casper P. Bots Giovanni FM Strippoli S. Raña Miguel Mas Serrano Silvia Claros María Fernanda Arenas Arias L. Petracci Mercedes Arana Pasquale De Rosa Alicia Hernández Marcia Simon Valentín Fabián Vergara M. Tosi Manuela Cernadas Inmaculada Ros Vilamajó D. Gravac M. Paulón L. Penayo Gabriela Carrizo Marco Ghiani George Perez O. Da Cruz D. Galarce Marı́a Clara Gravielle Ester Del Vescovo R. Paparone Cristina Mira Edgardo Mojico Osvaldo Hermida D. Florio M. Yucoswky W. Labonia D Mesa Rubio Giulia Di Napoli A. Fernández H.J. Altman J Rodriguez Sergio E. Serrano Guido Valle Marek Łobos V. Acosta G. Corpacci M. Josefina Jofré L. Gianoni Gustavo Ignacio Chiesura M. Capdevila Jesús Lechuga Montenegro J. Bequi Julie-Anne Dayer Ana María Gómez Caterina Calderón E. Abrego C. Cechín J. García Javier Corral Marcela Natiello Ana Fuentes Coronel Marília C Muniz Víctor Muñiz-Sánchez Aurelio Bonelli Francesca Sánchez Salvador E. Maestre Pérez Susana Olivera M. Constanza Camargo Viviana Avalos E. Geandet Mario Sánchez‐Canteli Antonio Escobar Elisama Araújo de Sena Silvia Tirado A. Peñalba Gustavo Neme Miguel Cisneros R. Oliszewski

Dental disease is more extensive in adults with chronic kidney disease, but whether dental health and behaviors are associated survival the setting of hemodialysis unknown.Prospective multinational cohort.4,205 treated long-term hemodialysis, 2010 to 2012 (Oral Diseases Hemodialysis [ORAL-D] Study).Dental as assessed by a standardized examination using World Health Organization guidelines personal oral care, including edentulousness; decayed, missing, filled teeth index; brushing flossing;...

10.1053/j.ajkd.2015.04.051 article EN cc-by-nc-nd American Journal of Kidney Diseases 2015-06-25

People with end-stage kidney disease treated dialysis experience high rates of premature death that are at least 30-fold the general population, and have markedly impaired quality life. Despite this, interventions lower risk factors for mortality (including antiplatelet agents, epoetins, lipid lowering, vitamin D compounds, or dose) not been shown to improve clinical outcomes this population. Although may be improving overall, additional modifiable determinants health in people need...

10.1186/1471-2369-14-90 article EN cc-by BMC Nephrology 2013-04-19

Introduction Adults with end-stage kidney disease (ESKD) treated haemodialysis experience mortality of between 15% and 20% each year. Effective interventions that improve health outcomes for long-term dialysis patients remain unproven. Novel testable determinants in are needed. Nutrition dietary patterns potential factors influencing other settings warrant exploration multinational studies men women dialysis. We report the protocol “DIETary intake, death hospitalisation adults HaemoDialysis...

10.1136/bmjopen-2014-006897 article EN cc-by-nc BMJ Open 2015-03-01

Vaccinating patients receiving dialysis may prevent morbidity and mortality in this vulnerable population. The National Forum of End-Stage Renal Disease Networks (the Forum) published a revised vaccination toolkit 2021 to update evidence recommendations on for dialysis. Significant changes the last 10 years include more data supporting use high-dose influenza vaccine, introduction Heplisav-B vaccine hepatitis B, pneumococcal vaccines, including approval PCV15 PCV20 replace PCV13 PPSV23...

10.1016/j.xkme.2023.100775 article EN cc-by Kidney Medicine 2023-12-09

Dialysis patients are particularly vulnerable to sudden acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which justifies their priority access vaccination in many countries.Even though vaccine response level can be regarded as excellent (~90%), several studies [1-3] have nonetheless found antibody titres significantly lower than those observed the general population.In this context, French National Authority for Health recommends adjusting schedules haemodialysis (HD) and...

10.1093/ndt/gfab224 article EN other-oa Nephrology Dialysis Transplantation 2021-07-19

Oral disease is a potentially treatable determinant of mortality and quality life. No comprehensive multinational study to quantify oral burden identify candidate preventative strategies has been performed in the dialysis setting.The ORAL hemoDialysis (ORALD) was prospective adults treated with hemodialysis Europe (France, Hungary, Italy, Poland, Portugal Spain) Argentina. assessed using standardized WHO methods. Participants self-reported health practices symptoms. Sociodemographic clinical...

10.1093/ndt/gfv413 article EN Nephrology Dialysis Transplantation 2015-12-29

Periodontitis is associated with cardiovascular mortality in the general population and adults chronic diseases. However, it unclear whether periodontitis predicts survival setting of kidney failure.ORAL-D was a propensity matched analysis 3338 dentate end-stage disease treated hemodialysis network Europe South America designed to examine association between all-cause cardiovascular-related people on long-term hemodialysis. Participants were 1:1 their score for moderate severe assessed using...

10.1186/s12882-017-0574-x article EN cc-by BMC Nephrology 2017-05-22

Background Chronic kidney disease is a risk factor for oral diseases, which may be associated with premature death. We evaluated the of all-cause and cardiovascular mortality mucosal lesions in adults failure treated long-term haemodialysis. Methods Oral (herpes, ulceration, neoformation, white lesion, red candidiasis, geographical tongue, petechial lesions, fissured tongue) were within Diseases Haemodialysis (ORAL-D) study, multinational cohort study 4726 haemodialysis adults. conducted cox...

10.1371/journal.pone.0218684 article EN cc-by PLoS ONE 2019-06-21
Coming Soon ...